Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Fonteyne

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 26, 2024
Is It Time to Reconsider the Place of Adjuvant Radiation Therapy After Radical Cystectomy?Valérie Fonteyne, Robert Huddart
Translational Andrology and Urology|April 13, 2018
Selecting candidates for early discharge after radical cystectomy for bladder cancerValérie Fonteyne, Elke Rammant, Karel Decaestecker
Translational Andrology and Urology|February 11, 2020
Predicting perioperative mortality after radical cystectomy: comorbidity assessment tools are only part of the puzzleValérie Fonteyne, Elke Rammant, Karel Decaestecker
Translational Andrology and Urology|January 23, 2018
Perspective on cytoreduction and metastasis-directed therapy in node positive and metastatic urothelial carcinoma of the bladderKarel Decaestecker, Valérie Fonteyne, Willem Oosterlinck
European Urology|July 14, 2019
Re: Gaëtan Devos, Gert De Meerleer, Steven Joniau. Have We Entered the Era of Imaging Before Salvage Treatment for Recurrent Prostate Cancer? Eur Urol 2019;76:265-7Aurélie De Bruycker, Valérie Fonteyne, Piet Ost
Asian Journal of Andrology|September 2, 2021
Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this "cort" is not out of order!Charles Van Praet, Valérie Fonteyne, Nicolaas Lumen
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2009
Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancerValérie Fonteyne, Geert Villeirs, Nicolaas Lumen, et al.
Lancet (London, England)|December 19, 2025
Prostate cancerValérie Fonteyne, Alison Tree, Elena Castro, et al.
Advances in Urology|December 23, 2011
Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancerValérie Fonteyne, Nicolaas Lumen, Geert Villeirs, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancerPiet Ost, Bart De Troyer, Valérie Fonteyne, et al.
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|September 26, 2024
Is It Time to Reconsider the Place of Adjuvant Radiation Therapy After Radical Cystectomy?Valérie Fonteyne, Robert Huddart
Translational Andrology and Urology|April 13, 2018
Selecting candidates for early discharge after radical cystectomy for bladder cancerValérie Fonteyne, Elke Rammant, Karel Decaestecker
Translational Andrology and Urology|February 11, 2020
Predicting perioperative mortality after radical cystectomy: comorbidity assessment tools are only part of the puzzleValérie Fonteyne, Elke Rammant, Karel Decaestecker
Translational Andrology and Urology|January 23, 2018
Perspective on cytoreduction and metastasis-directed therapy in node positive and metastatic urothelial carcinoma of the bladderKarel Decaestecker, Valérie Fonteyne, Willem Oosterlinck
European Urology|July 14, 2019
Re: Gaëtan Devos, Gert De Meerleer, Steven Joniau. Have We Entered the Era of Imaging Before Salvage Treatment for Recurrent Prostate Cancer? Eur Urol 2019;76:265-7Aurélie De Bruycker, Valérie Fonteyne, Piet Ost
Asian Journal of Andrology|September 2, 2021
Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this "cort" is not out of order!Charles Van Praet, Valérie Fonteyne, Nicolaas Lumen
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2009
Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancerValérie Fonteyne, Geert Villeirs, Nicolaas Lumen, et al.
Lancet (London, England)|December 19, 2025
Prostate cancerValérie Fonteyne, Alison Tree, Elena Castro, et al.
Advances in Urology|December 23, 2011
Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancerValérie Fonteyne, Nicolaas Lumen, Geert Villeirs, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2010
A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancerPiet Ost, Bart De Troyer, Valérie Fonteyne, et al.
Pageof 14